SCHEMBL11229892

SCHEMBL11229892

CCCCCCCCCCCCCCCCNc1ccc(C=CC(=O)OCC)cc1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.57
CA1 P00915 1/20 0.57
CA2 P00918 1/20 0.57
CA7 P43166 1/20 0.57
CA9 Q16790 1/20 0.57
CA14 Q9ULX7 1/20 0.57
CYP3A4 P08684 1/20 0.51
APP P05067 5/20 0.50
TTR P02766 1/20 0.50
DPP4 P27487 1/20 0.50
EGFR P00533 1/20 0.48
MAOB P27338 1/20 0.46
FDPS P14324 1/20 0.44
POLB P06746 1/20 0.44
PLK1 P53350 2/20 0.44
TDP1 Q9NUW8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11229891 1.00 CA12 (0.57) CA12CA1CA2CA7CA9
SCHEMBL11302053 0.92 CA12 (0.49) CA12CA1CA2CA7CA9
SCHEMBL11242232 0.91 CA12 (0.47) CA12CA1CA2CA7CA9
SCHEMBL11228477 0.91 CA12 (0.47) CA12CA1CA2CA7CA9
SCHEMBL11249659 0.91 CA12 (0.47) CA12CA1CA2CA7CA9
SCHEMBL11228482 0.91 CA12 (0.47) CA12CA1CA2CA7CA9
SCHEMBL11242246 0.91 CA12 (0.47) CA12CA1CA2CA7CA9
SCHEMBL11249654 0.91 CA12 (0.47) CA12CA1CA2CA7CA9
SCHEMBL11241213 0.89 APP (0.51) CA12CA1CA2CA7CA9
SCHEMBL11241216 0.89 APP (0.51) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4348399-A Antiatherosclerotic and hypolipidemic 4-(monoalkylamino)phenyl alkane, alkene and alkyne carbinols, aldehydes, carboxylic acids and derivatives AMERICAN CYANAMID COMPANY (US) 1982-09-07 US disclosed
US-4333940-A Ring-fluorinated 4-(monosubstituted-amino) phenyl compounds in inhibiting atherosclerotic lesion development AMERICAN CYANAMID COMPANY (US) 1982-06-08 US disclosed
US-4243609-A ANTILIPEMIC AGENTS, ANTIATHEROSCLEROTIC AGENTS AMERICAN CYANAMID COMPANY (US) 1981-01-06 US disclosed
EP-0003663-A2 Amino-substituted phenyl and heteroaryl compounds, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1979-08-22 EP disclosed